Clinical Trial Update: Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function [Phase 2]

View source ↗

Summary

Phase 2 trial assessing early conversion from calcineurin inhibitors to belatacept in renal transplant recipients with delayed graft function. Status is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Graft Function
• Kidney Transplant

Drugs mentioned

• belatacept (belatacept)

Snippet

Sponsor: Nair, Vinay, D.O. | Conditions: Delayed Graft Function, Kidney Transplant | Phase 2 | Status: UNKNOWN